Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion
Sign Up to like & getrecommendations! Published in 2019 at "Hepatology Research"
DOI: 10.1111/hepr.13294
Abstract: Lenvatinib is a novel multikinase inhibitor that has recently shown antitumor activity against hepatocellular carcinoma (HCC) in a phase III trial. We report the case of a woman in whom lenvatinib showed long‐term antitumor activity,… read more here.
Keywords: hepatocellular carcinoma; lenvatinib; term antitumor; long term ... See more keywords